Cell therapy weekly: new method for generating ultra-pure allogeneic cells for CAR-T therapies

This week: Jellagen (Cardiff, Wales) has announced successful closure of £1.9 million in seed funding to pursue the development of advanced collagen products for therapeutic applications and StemBioSys (TX, USA) has announced the introduction of a new chondrocyte culturing kit that improves cell attachment and proliferation in vitro. The news highlights: Generating ultra-pure allogeneic cells for CAR-T therapies: a new, straightforward protocol £1.9 million in seed funding secured for the development of advanced collagen therapeutics New chondrocyte culture method improves cell attachment and proliferation in vitro Generating ultra-pure allogeneic cells for CAR-T therapies: a new, straightforward protocol In a new...